Evidence map›Paper›PMID 34544946›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Behçet's Disease with Bilateral Renal Infarction Due to Mucormycosis.

Kumiko Shimoyama, Tomoyuki Niwa, Shogo Furukawa, Naomi Morishita, Yuka Nagakura, Haruka Yonezawa, Masakazu Hatakeyama, Yusuke Okubo, Daisuki Suzuki, Isao Kosugi and 2 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Kumiko ShimoyamaInternal Medicine 3, Hamamatsu University School of Medicine, Japan.
Tomoyuki NiwaInternal Medicine 1, Hamamatsu University School of Medicine, Japan.
Shogo FurukawaInternal Medicine 3, Hamamatsu University School of Medicine, Japan.
Naomi MorishitaDermatology, Hamamatsu University School of Medicine, Japan.
Yuka NagakuraDiagnostic Pathology, Hamamatsu University School of Medicine, Japan.
Haruka YonezawaInternal Medicine 3, Hamamatsu University School of Medicine, Japan.
Masakazu HatakeyamaInternal Medicine 3, Hamamatsu University School of Medicine, Japan.
Yusuke OkuboInternal Medicine 3, Hamamatsu University School of Medicine, Japan.
Daisuki SuzukiFutaba Clinic, Japan.
Isao KosugiRegenerative & Infectious Pathology, Hamamatsu University School of Medicine, Japan.
Kazuya ShiogamaFaculty of Medical Technology, Fujita Health University, Japan.
Noriyoshi OgawaInternal Medicine 3, Hamamatsu University School of Medicine, Japan.
Hamamatsu University School of Medicine · JPFujita Health University · JPFutaba clinic · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of Behçet's disease with renal infarction due to mucormycosis. A 76-year-old man with entero-Behçet's disease had been treated with glucocorticoid and tumor necrosis factor (TNF) inhibitors. His entero-Behçet's disease was refractory to these treatments, and ileocecal resection was performed. After the operation, renal infarction that was unresponsive to anticoagulation therapy developed. He ultimately died of renal failure due to renal infarction. At the autopsy, histopathology of abundant hyphae in the renal vessel wall revealed mucormycosis. Renal mucormycosis is an important cause of renal failure with renal infarction in immunocompromised patients.

Indexed as

Behcet SyndromeMucormycosisAgedGlucocorticoidsHumansInfarctionMaleTumor Necrosis Factor InhibitorsGlucocorticoidsTumor Necrosis Factor Inhibitorsimmunocompromised hostsmucormycosisrenal infarction

Identifiers

PMID34544946
PMCPMC9038466
OpenAlexW3199092309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.